PDGF Receptor alpha Antibody from Cell Signaling Technology

Yes, the PDGF Receptor alpha Antibody has been shown to work in applications related to oligodendrocyte precursor cells, particularly in studies investigating their interactions with endothelial cells during white matter vascularization, as highlighted in the research by Chavali et al. (2020).

The PDGF Receptor alpha Antibody has been utilized in immunohistochemistry applications, as evidenced by its use in studies involving mouse models, such as those examining the differentiation of oligodendrocyte precursor cells and their role in demyelination and remyelination processes (Cui et al., 2019; Marechal et al., 2022).

The PDGF Receptor alpha Antibody is reactive with both human and mouse species. This cross-reactivity can be beneficial for comparative studies involving human-derived samples and mouse models, allowing for consistent analysis across different experimental setups (Fusar Poli et al., 2013).

This antibody has been cited in various applications, including Western blotting, flow cytometry, and immunoprecipitation. Its versatility in these applications suggests it can be effectively used for detecting PDGF receptor alpha in different experimental contexts, such as studying signaling pathways in glioblastoma resistance to therapies (Liu et al., 2018).